Treatment of Diabetic Foot Ulcers Using a Blood Bank Platelet Concentrate
- 1 March 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 125 (3), 944-952
- https://doi.org/10.1097/prs.0b013e3181cb6589
Abstract
Many clinical trials have shown the effectiveness of platelet releasate on chronic wound healing, but large volumes of blood must be aspirated from patients and a platelet separator is required. Moreover, in the case of using homologous platelets, time and effort are needed to locate a suitable donor, and the donor's blood sample must be tested for a history of infectious disease. The current study was undertaken to evaluate the effect of a straightforward method using a blood bank platelet concentrate in treating diabetic foot ulcers. Fifty-two patients with diabetic foot ulcers were treated using a blood bank platelet concentrate. A control treatment (i.e., treatment with topical fibrinogen and thrombin) was performed on 48 patients. Twelve weeks after treatment, the percentage of complete healing, mean healing time, percentage of wound shrinkage, and patient satisfaction were compared. Complete wound healing was achieved in 79 percent of the blood bank platelet concentrate-treated group and 46 percent of the control group (p < 0.05). The times required for complete healing were 7.0 +/- 1.9 and 9.2 +/- 2.2 weeks in the blood bank platelet concentrate-treated and control groups, respectively (p < 0.05). The degrees of wound shrinkage were 96.3 +/- 7.8 and 81.6 +/- 19.7 percent for the treated and control groups, respectively (p < 0.05). Patient satisfaction with the blood bank platelet concentrate treatment yielded better results than the control method (mean score, 7.6 +/- 1.6 and 5.3 +/- 1.4, respectively; p < 0.05). No adverse events related to the study treatment occurred. Treatment of diabetic foot ulcers using a blood bank platelet concentrate showed results superior to control treatment. A blood bank platelet concentrate offers a simple and effective treatment for diabetic foot ulcers.Keywords
This publication has 12 references indexed in Scilit:
- Potential Use of Blood Bank Platelet Concentrates to Accelerate Wound Healing of Diabetic UlcersAnnals of Plastic Surgery, 2007
- Platelet gel for healing cutaneous chronic woundsTransfusion and Apheresis Science, 2004
- Platelet-rich plasma: evidence to support its useJournal of Oral and Maxillofacial Surgery, 2004
- Cytokine manipulation of the woundClinics in Plastic Surgery, 2003
- Effectiveness of Platelet Releasate for the Treatment of Diabetic Neuropathic Foot UlcersDiabetes Care, 2001
- Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacyWound Repair and Regeneration, 2000
- Growth factors secreted by fibroblasts: role in healing diabetic foot ulcersDiabetes, Obesity and Metabolism, 1999
- Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of L‐lactateWound Repair and Regeneration, 1998
- A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: A preliminary reportJournal of Vascular Surgery, 1991
- Classification and Treatment of Chronic Nonhealing WoundsAnnals of Surgery, 1986